Literature DB >> 23537348

Competing with the conventional wisdom: newspaper framing of medical overtreatment.

Kim Walsh-Childers1, Jennifer Braddock.   

Abstract

Overtreatment, defined as the use of medical tests, products, and services that are not medically necessary or beneficial to the patient, may account for as much as 30% of all U.S. health care expenditures. This article describes a study of the framing of this important health and economic issue in elite U.S. newspapers from January 1, 2007, through December 31, 2010. Within 98 articles providing some mention of overtreatment, analysis revealed three major frames: uncertainty, cost, and legal issues. Within the uncertainty frame, there was a remarkable emphasis on cancer testing and treatment as a driver of overutilization, which may suggest to readers that overtreatment does not occur or is not important in other types of medical care. Relatively few stories paid much attention to the financial costs of overtreatment.

Entities:  

Mesh:

Year:  2013        PMID: 23537348     DOI: 10.1080/10410236.2012.730173

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  3 in total

1.  How much dentists are ethically concerned about overtreatment; a vignette-based survey in Switzerland.

Authors:  Ali Kazemian; Isabelle Berg; Christina Finkel; Shahram Yazdani; Hans-Florian Zeilhofer; Philipp Juergens; Stella Reiter-Theil
Journal:  BMC Med Ethics       Date:  2015-06-19       Impact factor: 2.652

2.  Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.

Authors:  Mary O'Keeffe; Alexandra Barratt; Christopher Maher; Joshua Zadro; Alice Fabbri; Mark Jones; Ray Moynihan
Journal:  BMJ Open       Date:  2019-08-24       Impact factor: 2.692

3.  Impact of the shared decision-making process on lung cancer screening decisions.

Authors:  Naomi Q P Tan; Shawn P E Nishi; Lisa M Lowenstein; Tito R Mendoza; Maria A Lopez-Olivo; Laura C Crocker; Karen R Sepucha; Robert J Volk
Journal:  Cancer Med       Date:  2021-12-28       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.